MDC Partners (MDCA) Reports Q2 EPS of 33c
Tweet
Share
E-mailGet Alerts MDCA Hot Sheet
Price: $5.42 --0%
Financial Fact:
Nonoperating Income (Expense), Total: -22.33M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Nonoperating Income (Expense), Total: -22.33M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
MDC Partners (NASDAQ: MDCA) reported Q2 EPS of $0.33, may not compare to the analyst estimate of $0.15. Revenue for the quarter came in at $317.7 million versus the consensus estimate of $311.13 million.
2014 Adjusted EBITDA guidance was increased to $184-$188 million.
For earnings history and earnings-related data on MDC Partners (MDCA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
